EXAI

Exscientia (EXAI)

Exscientia PLC

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:EXAI

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/08/30	21:57	Edgar (US Regulatory)	Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]	NASDAQ:EXAI	Exscientia PLC
2024/08/29	05:42	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:EXAI	Exscientia PLC
2024/08/29	01:11	Business Wire	Exscientia wird auf der 22nd Annual Global Healthcare Conference Präsentation durchführen	NASDAQ:EXAI	Exscientia PLC
2024/08/29	01:11	Business Wire	Exscientia participera à la 22e conférence annuelle de Morgan Stanley sur les soins médicaux dans le monde	NASDAQ:EXAI	Exscientia PLC
2024/08/28	20:00	Business Wire	Exscientia to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference	NASDAQ:EXAI	Exscientia PLC
2024/08/24	05:07	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:EXAI	Exscientia PLC
2024/08/15	20:19	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:EXAI	Exscientia PLC
2024/08/15	20:00	Business Wire	Exscientia Business Update for Second Quarter and First Half 2024	NASDAQ:EXAI	Exscientia PLC
2024/08/09	18:44	IH Market News	TSMC July Revenue Surges 45%, Nasdaq Accelerates Penny Stock Delistings, Moody’s Downgrades Intel to BAA1, and More	NASDAQ:EXAI	Exscientia PLC
2024/08/09	06:19	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:EXAI	Exscientia PLC
2024/08/08	20:39	GlobeNewswire Inc.	Recursion and Exscientia Enter Definitive Agreement to Create a Global Technology-Enabled Drug Discovery Leader with End-to-End Capabilities	NASDAQ:EXAI	Exscientia PLC
2024/07/25	05:06	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:EXAI	Exscientia PLC
2024/07/19	01:36	Business Wire	Exscientia erwirbt volle Rechte an potenziellem CDK7-Inhibitor der Spitzenklasse vor der Veröffentlichung von Phase-1-Dosis-Eskalationsdaten	NASDAQ:EXAI	Exscientia PLC
2024/07/18	23:20	Business Wire	Exscientia acquiert les droits complets d’un inhibiteur potentiel de CDK7, le meilleur de sa catégorie, avant la publication des données de dose croissante de phase 1	NASDAQ:EXAI	Exscientia PLC
2024/07/18	20:24	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:EXAI	Exscientia PLC
2024/07/18	20:00	Business Wire	Exscientia Acquires Full Rights to Potential Best-in-Class CDK7 Inhibitor Ahead of Phase 1 Dose Escalation Data Readout	NASDAQ:EXAI	Exscientia PLC
2024/07/11	06:44	Business Wire	Exscientia lance une plateforme AWS optimisée par l'IA pour promouvoir la découverte de médicaments	NASDAQ:EXAI	Exscientia PLC
2024/07/11	04:13	Business Wire	Exscientia bringt KI-gestützte AWS-Plattform zur Verbesserung der Arzneimittelforschung auf den Markt	NASDAQ:EXAI	Exscientia PLC
2024/07/10	20:00	Business Wire	Exscientia Launches AWS AI-powered Platform to Advance Drug Discovery	NASDAQ:EXAI	Exscientia PLC
2024/06/25	18:45	PR Newswire (US)	EXAI LAWSUIT ALERT: The Gross Law Firm Notifies Exscientia plc Investors of a Class Action Lawsuit and Upcoming Deadline	NASDAQ:EXAI	Exscientia PLC
2024/06/20	18:45	PR Newswire (US)	Exscientia plc Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before June 25, 2024 to Discuss Your Rights - EXAI	NASDAQ:EXAI	Exscientia PLC
2024/06/17	18:45	PR Newswire (US)	Shareholders that lost money on Exscientia plc(EXAI) Urged to Join Class Action - Contact The Gross Law Firm to Learn More	NASDAQ:EXAI	Exscientia PLC
2024/06/10	18:45	PR Newswire (US)	June 25, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against EXAI	NASDAQ:EXAI	Exscientia PLC
2024/06/07	05:16	Business Wire	Exscientia ernennt neue Führungskräfte zur Stärkung der Auswirkungen integrierter Technologien und um den Schwerpunkt auf klinische Entwicklungskompetenz in der Onkologie zu richten	NASDAQ:EXAI	Exscientia PLC
2024/06/07	05:12	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:EXAI	Exscientia PLC
2024/06/07	04:49	Business Wire	Exscientia nomme de nouveaux dirigeants pour accentuer l'impact des technologies intégrées et recentrer l'expertise en développement clinique sur l'oncologie	NASDAQ:EXAI	Exscientia PLC
2024/06/06	20:00	Business Wire	Exscientia Appoints New Leaders to Strengthen the Impact of Integrated Technologies and Focus Clinical Development Expertise in Oncology	NASDAQ:EXAI	Exscientia PLC
2024/06/05	18:45	PR Newswire (US)	Shareholders that lost money on Exscientia plc(EXAI) should contact The Gross Law Firm about pending Class Action - EXAI	NASDAQ:EXAI	Exscientia PLC
2024/05/31	03:30	Business Wire	Exscientia participera à des conférences d'investisseurs au mois de juin	NASDAQ:EXAI	Exscientia PLC
2024/05/31	02:58	Business Wire	Exscientia präsentiert sich auf kommenden Investorenkonferenzen im Juni	NASDAQ:EXAI	Exscientia PLC